Evaluation and review of pharmacoeconomic models.
Difficult decisions as to whether to provide or withhold drug therapy to patients are needed to be made on a daily basis. These decisions should be based on carefully designed and constructed pharmacoeconomic models, with explicit and justifiable parameter values, validated by publication in peer-reviewed literature. This review describes and evaluates the common types of pharmacoeconomic models, modelling approaches and methods. It also discusses model quality, validity and usefulness.
University of Southern California, Department of Pharmaceutical Economics and Policy, CA, USA. JHay@usc.edu
Joel W
JW
Hay
D003362:Cost-Benefit Analysis; D003663:Decision Trees; D017850:Economics, Pharmaceutical; D008390:Markov Chains; D018803:Models, Economic; D009010:Monte Carlo Method; D019057:Quality-Adjusted Life Years; D015203:Reproducibility of Results; D035501:Uncertainty